Role of TGF-β in a mouse model of high turnover renal osteodystrophy. - Wikidata - wikimedia - TriplyDB

Role of TGF-β in a mouse model of high turnover renal osteodystrophy.

Role of TGF-β in a mouse model of high turnover renal osteodystrophy.

http://www.wikidata.org/entity/Q33827652

about

Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome Bone remodeling markers and bone metastases: From cancer research to clinical implications Effects of CreERT2, 4-OH Tamoxifen, and Gender on CFU-F Assays Osteoclasts-Key Players in Skeletal Health and Disease.Inhibition of GSK-3β increases trabecular bone volume but not cortical bone volume in adenine-induced uremic mice with severe hyperparathyroidism.Sclerostin and CKD-MBD.Sclerostin, Osteocytes, and Chronic Kidney Disease - Mineral Bone Disorder.Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease.Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease.Fibroblast Growth Factor 23 Regulation by Systemic and Local Osteoblast-Synthesized 1,25-Dihydroxyvitamin D.Rescue of a cherubism bone marrow stromal culture phenotype by reducing TGFβ signaling.TGF-Beta Signaling in Bone with Chronic Kidney Disease

P2860

Q35224497-CD1B7875-A675-44A1-97D2-D323DC7B7E13 Q35531006-16FA829D-6114-45D6-AA1F-BCBC897466D7 Q35909527-6F494545-7697-4208-BE41-616F6FD5CA35 Q37036135-69D192D9-2BCD-4CF4-ACC2-D0465AB888AB Q37418997-019A01FF-8A75-4D5C-94D5-9D22E956D19D Q38359423-5E1E2B1D-91D4-4433-98B9-D74DF484C883 Q38569480-B2961C2A-8210-435B-A79C-6C28EA4DACEB Q39595554-5232AD04-465F-4E72-A635-22BF76488381 Q41146384-83BB6553-A708-4405-B22C-50084B456C21 Q50347097-AFC102A8-9EC0-4813-925A-A01342C964B3 Q51741155-0678213A-8026-4EFF-BB8F-6AFAB6C066B7 Q58789309-9AF9CF71-3E4F-419E-A0F0-55AF0A924805

P2860

Role of TGF-β in a mouse model of high turnover renal osteodystrophy.

http://www.wikidata.org/entity/Q33827652

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Role of TGF-β in a mouse model of high turnover renal osteodystrophy.

@ast

Role of TGF-β in a mouse model of high turnover renal osteodystrophy.

@en

type

label

Role of TGF-β in a mouse model of high turnover renal osteodystrophy.

@ast

Role of TGF-β in a mouse model of high turnover renal osteodystrophy.

@en

prefLabel

Role of TGF-β in a mouse model of high turnover renal osteodystrophy.

@ast

Role of TGF-β in a mouse model of high turnover renal osteodystrophy.

@en

P1433

Q33827652-250632AD-99A4-4860-ACBE-B69F62871DB9

P1476

Q33827652-8D6E99BE-7BEC-4FA9-AE4B-D38D4E7761EB

P2093

Q33827652-0A36949E-7A86-46CD-A7A9-2B6750F8B7FC

Q33827652-0E911025-7CC4-4FF8-854A-A9EC8C5ACBC6

Q33827652-12A67A9F-07B9-4C40-858C-E4532A1ABA50

Q33827652-26B74251-F6EE-4404-ABC4-376CFBE244D4

Q33827652-311AB7E6-11B7-44F8-8432-5DD6921E94BC

Q33827652-448B58CA-9110-4808-A41C-0AF1DA34A65C

Q33827652-629B01BF-AB33-4084-9059-A2E3B84C6BD8

Q33827652-6C1CB692-808D-46EB-8416-8C24136C8A81

Q33827652-6F29588E-5833-4FD2-AB20-839AFB391A18

Q33827652-7B0E7470-71C6-4FB8-B8F3-9805E22A18CC

P2860

Q33827652-04471266-0352-4D80-A7CC-E2DE519C555B

Q33827652-082ED8EF-C910-4638-8D4D-3825D96FA00F

Q33827652-09AF6BDB-6102-4AE9-AB84-10A6858C5600

Q33827652-0AF2B8B4-1AD6-43A9-B0CF-7BBA1616E0E2

Q33827652-1479AE49-8613-48C8-AEFE-539712262AD7

Q33827652-18E782C7-C268-428D-AA0A-018D2383DBCC

Q33827652-1B61E170-CA52-44C7-8313-D06FCB7B93A7

Q33827652-1F9A5F9E-005F-419C-A6C7-BA4F160CBB13

Q33827652-22924B18-3C14-4A0A-8E50-FFB519485AEC

Q33827652-22C5CB02-9A9D-4637-A47D-DC58C45975AF

P304

Q33827652-FAD623E3-0709-497B-A6B4-8A2E0E7FE83E

P31

Q33827652-4FA7BC8D-3FCF-4754-ABBC-96CFBF8E2C53

P356

Q33827652-7B0BB632-6927-4DE5-9AE0-CAF08B96135D

P433

Q33827652-A25BD078-DE0C-47EC-9139-A822C6E3CB36

P478

Q33827652-61C799F2-11E2-470F-95CD-C6742365E30E

P50

Q33827652-63255001-4E6D-406C-AE98-7AD5FBC1EC24

Q33827652-F9AE0CCE-3B50-4D2C-BAA1-26B1E0C14A2A

P577

Q33827652-95014A20-01DE-4FC7-B27E-7362524E56C3

P698

Q33827652-676E63CC-DAE4-4F18-AA62-B44824C89B97

P932

Q33827652-FCDFD671-E132-4739-B226-F6C0B2E6CCF9

P356

P1433

Journal of Bone and Mineral Research

P1476

Role of TGF-β in a mouse model of high turnover renal osteodystrophy.

@en

P2093

Brian Kelley

http://www.w3.org/2001/XMLSchema#string

Gehua Zhen

http://www.w3.org/2001/XMLSchema#string

Hong Ling

http://www.w3.org/2001/XMLSchema#string

Joseph H Boulanger

http://www.w3.org/2001/XMLSchema#string

Katie Malley

http://www.w3.org/2001/XMLSchema#string

Lucy Phillips

http://www.w3.org/2001/XMLSchema#string

Paul C Dechow

http://www.w3.org/2001/XMLSchema#string

Russell Gotschall

http://www.w3.org/2001/XMLSchema#string

Shiguang Liu

http://www.w3.org/2001/XMLSchema#string

Steven R Ledbetter

http://www.w3.org/2001/XMLSchema#string

P2860

The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis

Arterial calcification in chronic kidney disease: key roles for calcium and phosphate

Catabolic and anabolic actions of parathyroid hormone on the skeleton

TGF-β and BMP signaling in osteoblast differentiation and bone formation

Treatment of a murine model of high-turnover renal osteodystrophy by exogenous BMP-7

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

Nek8 regulates the expression and localization of polycystin-1 and polycystin-2

The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone.

P304

1141-1157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JBMR.2120

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Teresita M. Bellido

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24166835

http://www.w3.org/2001/XMLSchema#string

P932

4076799

http://www.w3.org/2001/XMLSchema#string